Effect Of Weight Loss on Menopausal Symptoms and Inflammatory Biomarkers in Post-Menopausal Women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201911724355280

Enrollment

Registered

2019-11-18

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopausal symptoms improvement

Interventions

control group

diet and excercise group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: a. postmenopausal women (natural menopause) b. Patient with BMI (25-35) c. Patient with no chronic or serious disease (diabetic, cancer)

Exclusion criteria

Exclusion criteria: a. Using of postmenopausal hormone therapy within the prior 3 months b. Women with oophorectomy. c. Using of weight loss medications. d. Any joint disease interferes with movement (osteoarthritis). e. Those with mental or physical condition that could interfere with the understanding of the questionnaire

Design outcomes

Primary

Measure	Time frame
1.To measure the association of body mass index (BMI) and body fat distribution with postmenopausal symptom. 2.To study the effect of postmenopausal obesity on C-reactive proteins (CRP).	—

Secondary

Measure	Time frame
To assess weight loss effect on inflammatory biomarker (CRP).	—

Countries

Egypt

Contacts

Public Contactomima taha

suez canal university

omimatharwat@yahoo.com01223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026